Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

Submitted by admin on March 3, 2025 - 10:19am
Source: 
Clinical Trials Arena
News Tags: 
Amgen
AstraZeneca
clinical trials
Tezspire
chronic rhinosinusitis with nasal polyps
Headline: 
Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP
snippet: 

Amgen and AstraZeneca have reported complete outcomes from the registrational Phase III WAYPOINT trial of Tezspire (tezepelumab-ekko) for treating chronic rhinosinusitis with nasal polyps (CRSwNP).

Do Not Allow Advertisers to Use My Personal information